Ej Brandreth Email Address

Senior Vice President, Global Quality

Develops DNA based immunotherapies targeting cancers and infectious diseases. Best-in-class T cell responses have also generated clinically relevant efficacy.

E.J. Brandreth, MBA, is the Senior Vice President of Quality at Inovio Pharmaceuticals. He has a unique history of highly successful core team leadership from start-up through commercialization at IDEC, BioMarin and Althea. Employment; -Inovio 2014 to Present SVP QA, overseeing Global Quality for international plasmid and device production and distribution - Althea, 2008-2014, Sr. VP Quality and Regulatory, launched Nabi-HB, Ajinomoto acquisition - Favrille, 2004-2008, Vice President, Quality, patient-specific antibodies - BioMarin,1999-2004, Sr. Director of QA, launched Aldurazyme and Naglazyme - IDEC, 1993-1999, Quality and Regulatory Management, launched Zevalin and Rituximab Industry Influencer; - UCSD Deans Leadership Council, Div. Biological Sciences, 2020-present - Chairman, Speaker, Cell and Gene Therapy Conference, Berlin, 2019 - Co-Chair FDA/PDA Global Supply Chain Conference 2013 - Co-Chair, Author of PDA TR 14, Validation of Chromatography - Author PDA TR 42, Process Validation for Biotechnology - Chairman of the PDA Biotech Advisory Board 2010-2014 - Director on PDA PSC, PCMO Boards - Director of BIOCOM FDA Advisory Board - Director for 10 years, VP and President of ISPE San Diego - BOD for Interphex. - Over 30 invited speaker events at key industry conferences - BA in Biology and MBA Specialties: Organizational management, product development, biotech facility design and validation, biotech process validation, clinical to commercial launch, Quality Control, cGMP and ICH Compliance, viral control, FDA/EMEA, mammalian/insect/microbial cell cultures, contract negotiations, M&A